Log in

NASDAQ:DOCUDocusign Stock Price, Forecast & News

$190.99
+12.03 (+6.72 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$178.52
Now: $190.99
$199.49
50-Day Range
$122.01
MA: $148.65
$190.99
52-Week Range
$43.13
Now: $190.99
$199.49
Volume13.23 million shs
Average Volume5.89 million shs
Market Capitalization$35.05 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.85
DocuSign, Inc. provides cloud based software in the United States. The company offers e-signature solution that enables businesses to digitally prepare, execute, and act on agreements. The company sells its products through direct, partner-assisted, and Web-based sales. It serves enterprise businesses, commercial businesses, and small businesses, such as professionals, sole proprietorships and individuals. The company was 2003 and is headquartered in San Francisco, California.
Read More
Docusign logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.29 out of 5 stars


Industry, Sector and Symbol

Industry Prepackaged software
Sub-IndustryN/A
Current SymbolNASDAQ:DOCU
CUSIPN/A
Phone415-489-4940

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$973.97 million
Book Value$3.01 per share

Profitability

Net Income$-208,360,000.00

Miscellaneous

Employees3,909
Market Cap$35.05 billion
Next Earnings Date9/3/2020 (Estimated)
OptionableOptionable

Receive DOCU News and Ratings via Email

Sign-up to receive the latest news and ratings for DOCU and its competitors with MarketBeat's FREE daily newsletter.

Docusign (NASDAQ:DOCU) Frequently Asked Questions

How has Docusign's stock been impacted by COVID-19 (Coronavirus)?

Docusign's stock was trading at $75.00 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, DOCU stock has increased by 154.7% and is now trading at $190.99. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Docusign?

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Docusign in the last year. There are currently 6 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Docusign.

When is Docusign's next earnings date?

Docusign is scheduled to release its next quarterly earnings announcement on Thursday, September 3rd 2020. View our earnings forecast for Docusign.

How were Docusign's earnings last quarter?

Docusign Inc (NASDAQ:DOCU) posted its quarterly earnings data on Thursday, June, 4th. The company reported $0.12 EPS for the quarter, beating the consensus estimate of $0.10 by $0.02. The company had revenue of $297.02 million for the quarter, compared to analysts' expectations of $281.12 million. Docusign had a negative net margin of 19.91% and a negative return on equity of 29.36%. Docusign's quarterly revenue was up 38.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.07 earnings per share. View Docusign's earnings history.

What guidance has Docusign issued on next quarter's earnings?

Docusign issued an update on its FY 2021 After-Hours earnings guidance on Thursday, June, 4th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.313-1.317 billion, compared to the consensus revenue estimate of $1.26 billion.

What price target have analysts set for DOCU?

18 Wall Street analysts have issued 12 month target prices for Docusign's stock. Their forecasts range from $52.00 to $210.00. On average, they anticipate Docusign's share price to reach $135.06 in the next year. This suggests that the stock has a possible downside of 29.3%. View analysts' price targets for Docusign.

Has Docusign been receiving favorable news coverage?

Press coverage about DOCU stock has been trending negative on Monday, according to InfoTrie. The research firm ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Docusign earned a news sentiment score of -2.1 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news about Docusign.

Are investors shorting Docusign?

Docusign saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 8,150,000 shares, an increase of 7.9% from the June 15th total of 7,550,000 shares. Based on an average daily trading volume, of 4,390,000 shares, the short-interest ratio is presently 1.9 days. Currently, 4.8% of the company's stock are sold short. View Docusign's Current Options Chain.

Who are some of Docusign's key competitors?

What other stocks do shareholders of Docusign own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Docusign investors own include NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Square (SQ), salesforce.com (CRM), Micron Technology (MU), Walt Disney (DIS), Netflix (NFLX), Trade Desk (TTD) and Paypal (PYPL).

Who are Docusign's key executives?

Docusign's management team includes the following people:
  • Mr. Daniel D. Springer, Pres, CEO & Director (Age 56)
  • Mr. Scott V. Olrich, Chief Operating Officer (Age 44)
  • Ms. Kirsten O. Wolberg, Chief Technology & Operations Officer (Age 51)
  • Mr. Michael J. Sheridan, Chief Financial Officer (Age 54)
  • Ms. Vivian Chow MacDonald, Chief Accounting Officer (Age 52)

When did Docusign IPO?

(DOCU) raised $542 million in an IPO on Friday, April 27th 2018. The company issued 21,700,000 shares at $24.00-$26.00 per share. Morgan Stanley and J.P. Morgan acted as the underwriters for the IPO and Citigroup, BofA Merrill Lynch, Deutsche Bank Securities, JMP Securities, Pper Jaffray and William Blair were co-managers.

What is Docusign's stock symbol?

Docusign trades on the NASDAQ under the ticker symbol "DOCU."

Who are Docusign's major shareholders?

Docusign's stock is owned by a variety of institutional and retail investors. Top institutional investors include Modus Advisors LLC (0.01%). Company insiders that own Docusign stock include Enrique T Salem, John M Hinshaw, Keith J Krach, Kirsten O Wolberg, Loren Alhadeff, Mary G Meeker, Peter Solvik, Reginald D Davis, Scott V Olrich and William Neil Hudspith. View institutional ownership trends for Docusign.

Which major investors are selling Docusign stock?

DOCU stock was sold by a variety of institutional investors in the last quarter, including Modus Advisors LLC. Company insiders that have sold Docusign company stock in the last year include Enrique T Salem, John M Hinshaw, Kirsten O Wolberg, Loren Alhadeff, Peter Solvik, and Scott V Olrich. View insider buying and selling activity for Docusign.

How do I buy shares of Docusign?

Shares of DOCU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Docusign's stock price today?

One share of DOCU stock can currently be purchased for approximately $190.99.

How big of a company is Docusign?

Docusign has a market capitalization of $35.05 billion and generates $973.97 million in revenue each year. The company earns $-208,360,000.00 in net income (profit) each year or ($0.94) on an earnings per share basis. Docusign employs 3,909 workers across the globe.

What is Docusign's official website?

The official website for Docusign is www.docusign.com.

How can I contact Docusign?

Docusign's mailing address is 221 Main St. Suite 1550, San Francisco CA, 94105. The company can be reached via phone at 415-489-4940 or via email at [email protected]

This page was last updated on 7/6/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.